| scholarly article | Q13442814 |
| P2093 | author name string | Tsutomu Hirano | |
| Yasuki Ito | |||
| Miki Fujimura | |||
| Motoko Ohta | |||
| P2860 | cites work | THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 |
| Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study | Q30979271 | ||
| Metabolic origins and clinical significance of LDL heterogeneity | Q34863756 | ||
| Measurement of small dense low-density lipoprotein particles | Q36154957 | ||
| Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese | Q37050848 | ||
| Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction | Q44144342 | ||
| A novel and simple method for quantification of small, dense LDL. | Q44535878 | ||
| Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 | ||
| Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia | Q46129313 | ||
| Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine | Q46863532 | ||
| Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. | Q51013164 | ||
| Low-density lipoprotein cholesterol can be chemically measured: a new superior method. | Q51568117 | ||
| Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles | Q58063479 | ||
| Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2Only Aggregation, of Low Density Lipoprotein (LDL) Particles | Q62023751 | ||
| Nondenaturing polyacrylamide gradient gel electrophoresis | Q69553541 | ||
| Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study | Q71971744 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 57-65 | |
| P577 | publication date | 2010-11-04 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Development of a homogeneous assay for measurement of small dense LDL cholesterol | |
| Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol | |||
| P478 | volume | 57 |
| Q88352529 | A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase |
| Q34793839 | Additive effects of postchallenge hyperglycemia and low-density lipoprotein particles on the risk of arterial stiffness in healthy adults. |
| Q35879603 | Atherosclerosis |
| Q55409636 | CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions? |
| Q37278677 | Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins |
| Q35432878 | Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women |
| Q37278608 | Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease |
| Q37586607 | Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin |
| Q33831184 | Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects |
| Q38104228 | Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials |
| Q37361667 | Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes |
| Q87344021 | Hepatic Effects of Estrogen on Plasma Distribution of Small Dense Low-Density Lipoprotein and Free Radical Production in Postmenopausal Women |
| Q51319691 | Increased levels of small dense low-density lipoprotein cholesterol associated with hemorheological abnormalities in untreated, early-stage essential hypertensives. |
| Q42688847 | Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus |
| Q26781851 | LDL electronegativity index: a potential novel index for predicting cardiovascular disease |
| Q34504402 | Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris |
| Q37609621 | Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels |
| Q34412975 | New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis |
| Q33580624 | Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease |
| Q64227549 | PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment |
| Q58774678 | Pathophysiology of Diabetic Dyslipidemia |
| Q35556548 | Prevalence of plasma small dense LDL is increased in obesity in a Thai population |
| Q33803712 | Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method |
| Q38851195 | Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial. |
| Q33717612 | Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. |
| Q37723285 | Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study |
Search more.